Provided by Tiger Trade Technology Pte. Ltd.

Xenon Pharmaceuticals

60.17
+0.01000.02%
Volume:23.38K
Turnover:1.40M
Market Cap:5.81B
PE:-12.79
High:60.19
Open:60.19
Low:59.61
Close:60.16
52wk High:72.66
52wk Low:35.60
Shares:96.64M
Float Shares:95.45M
Volume Ratio:0.61
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7061
EPS(LYR):-4.3646
ROE:-43.62%
ROA:-28.02%
PB:4.68
PE(LYR):-13.79

Loading ...

Jun 03, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 08, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2026

Major Issues Report

Form 8-K - Current report
Apr 13, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Apr 13, 2026

Major Issues Report

Form 8-K - Current report
Mar 13, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 13, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 13, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 13, 2026

Major Issues Report

Form 8-K - Current report
Mar 12, 2026

Major Issues Report

Form 8-K - Current report
Mar 11, 2026

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Mar 10, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 10, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 10, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 09, 2026

Major Issues Report

Form 8-K - Current report
Feb 27, 2026

Major Issues Report

Form 8-K - Current report